Related Experiment Video
Updated: Jan 28, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
A high-throughput and rapid method for accurate identification of emerging multidrug-resistant Candida auris
Ausaf Ahmad1, Jonathan E Spencer1, Shawn R Lockhart2
1Enhanced Capacity Surge Laboratory, Reagent and Diagnostic Services Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) Centers for Disease Control & Prevention (CDC), Atlanta, Georgia.
Abstract:
Candida auris is an emerging multidrug-resistant yeast associated with invasive infection in healthcare settings. Recently, C auris cases in the United States have been detected in 11 states with the majority of cases in New York, New Jersey and Illinois. Rapid and accurate identification of C auris is critical for patient care and the implementation of public health measures to control the spread of infection. Our aim was to develop and validate a rapid DNA extraction method using the Roche MagNA Pure 96 instrument and a TaqMan real-time PCR assay for reliable, high-throughput identification of C auris. We evaluated 247 patient dermal swab samples previously analysed by culture/MALDI-TOF. The diagnostic sensitivity and specificity were 93.6% and 97.2%, respectively. The assay was highly reproducible with a detection limit of 1 C auris CFU/10 microL. A receiver operating characteristic curve analysis of the real-time PCR data showed an area of 0.982 under the curve, with a CT cut-off value of ≤37.0. The turnaround time from DNA extraction to real-time PCR results was approximately 200 samples/day. In conclusion, we successfully validated a rapid and high-throughput method for accurate and reproducible identification of C auris with a significantly reduced turnaround time compared to culture/MALDI-TOF based methods.
Insights
A new rapid DNA extraction and real-time PCR method accurately identifies the multidrug-resistant yeast Candida auris (C. auris). This high-throughput assay significantly reduces turnaround time for clinical and public health applications.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Molecular Diagnostics
Background:
- Candida auris is an emerging multidrug-resistant yeast causing invasive infections in healthcare settings.
- Increasing C. auris cases in the US necessitate rapid diagnostic tools for patient care and infection control.
- Accurate and timely identification of C. auris is crucial for public health interventions.
Purpose of the Study:
- To develop and validate a rapid DNA extraction method using the Roche MagNA Pure 96 instrument.
- To create and validate a TaqMan real-time PCR assay for high-throughput C. auris identification.
- To assess the diagnostic accuracy and efficiency of the developed method.
Main Methods:
- Evaluated 247 patient dermal swab samples previously analyzed by culture/MALDI-TOF.
- Utilized Roche MagNA Pure 96 for DNA extraction and TaqMan real-time PCR for C. auris detection.
- Performed receiver operating characteristic (ROC) curve analysis to determine optimal cut-off values.
Main Results:
- The assay demonstrated high diagnostic sensitivity (93.6%) and specificity (97.2%).
- Achieved a low limit of detection (1 C. auris CFU/10 µL) and high reproducibility.
- The method offers a high throughput of approximately 200 samples per day with a significantly reduced turnaround time.
Conclusions:
- A rapid, high-throughput DNA extraction and real-time PCR method for C. auris identification was successfully validated.
- The developed assay provides accurate and reproducible results, outperforming traditional methods in terms of speed.
- This method is suitable for clinical laboratories and public health surveillance of C. auris infections.
More Related Videos
Related Concept Videos
Methods of Classification and Identification
Emerging Adulthood
Introduction Cardiac Emergencies
Resistivity
Resistance
Applications of GIS: Disaster Management and Emergency Response

